Legal Opinion
In re BioAge Labs, Inc., Securities Litigation
District Court, N.D. California
Decided March 2, 2026No. 3:25-cv-00196Unknown
1Opinion
1 2 3 4 5 6 7 UNITED STATES DISTRICT COURT 8 NORTHERN DISTRICT OF CALIFORNIA 9 IN RE BIOAGE LABS, INC., 10 SECURITIES LITIGATION Case No. 25-cv-00196-RS 11 ORDER GRANTING MOTION TO 12 DISMISS AMENDED CLASS ACTION COMPLAINT WITH PREJUDICE 13 14 15 In this putative securities class action, the Southeastern Pennsylvania Transportation 16 Authority (SEPTA) sued BioAge Labs, averring that the offering documents BioAge issued in 17 connection with its initial public offering were misleading. Specifically, SEPTA claims that 18 BioAge’s offering documents failed adequately to disclose the risk that…
2Cases cited7 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Matrixx Initiatives, Inc. v. SiracusanoSupreme Court of the United States · 2011
- Omnicare, Inc. v. Laborers Dist. Council Constr. Industry Pension FundSupreme Court of the United States · 2015
- Inter-Local Pension Fund Gcc/i v. Rigel Pharmaceuticals, Inc.Court of Appeals for the Ninth Circuit · 2012
2 more not listed; retrieve them via the Exa API.